ALARIS Medical Systems to List on the New York Stock Exchange.Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--Sept. 3, 2003 ALARIS Medical Systems Inc. (AMEX AMEX See: American Stock Exchange :AMI) announced today that the listing of its common stock will be transferred to the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. (NYSE NYSE See: New York Stock Exchange ) with trading on the NYSE to begin on Sept. 25, 2003. The company's common stock is currently listed on the American Stock Exchange American Stock Exchange (AMEX) Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921. (AMEX). Its shares will continue to trade under its ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors (AMI) on the AMEX through the close of trading on September 24th, and thereafter on the NYSE under the same symbol. ALARIS Medical Systems Inc. develops practical solutions for medication safety. It is the global market leader in infusion therapy and IV medication safety. Additional information on the company can be found at http://www.alarismed.com. "Listing on the New York Stock Exchange represents an important milestone for ALARIS Medical Systems," said David L. Schlotterbeck, president and chief executive officer. "The past 24 months have been especially exciting for our investors and for us, as our stock has experienced a ten-fold increase in price. "ALARIS's equity market capitalization Equity Market Capitalization A measure of the total market value of an equity market. The measure is calculated by taking the market capitalization of all companies in the equity market and adding them together to arrive at the capitalization for the market as a whole. now exceeds $1.0 billion and nearly one-third of our business is generated outside the United States," Schlotterbeck continued. "The NYSE, the preeminent securities trading market in the world, is the appropriate home for our shares to trade. The NYSE's global recognition will assist us greatly in communicating our mission to improve Medication Safety at the Point of Care(TM) to investors and customers around the world." About ALARIS Medical Systems Inc. ALARIS Medical Systems Inc. designs, manufactures and markets intravenous (IV) medication delivery and infusion therapy devices, needle-free disposables and related monitoring equipment in the United States and internationally. ALARIS Medical Systems' proprietary Guardrails(R) Safety Software, its other "smart" technologies and its "smart" services help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and also gather and record clinical information for review, analysis and transcription. The company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors. With headquarters in San Diego, ALARIS Medical Systems employs approximately 2,900 people worldwide. This news release contains forward-looking statements as defined in the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Persons reading this release are cautioned that such forward-looking statements involve risks and uncertainties, including the significant leverage to which the company is subject. Such risk factors are detailed in the Securities and Exchange Commission filings of ALARIS Medical Systems Inc., formerly known as ALARIS Medical Inc., including Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended Dec. 31, 2002, and other filings. On June 30, 2003 the two companies were merged. Subsequent SEC filings are available only for ALARIS Medical Systems Inc. The company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion